AAV8-Mediated Liver-Directed Gene Therapy as a Potential Therapeutic Option in Adults with Glycogen Storage Disease Type Ia (GSDIa): Results from a Phase 1/2 Clinical Trial

被引:0
|
作者
Weinstein, David A. [1 ]
Ahmad, Ayesha [2 ]
Rodriguez-Buritica, David F. [3 ]
Mitchell, John [4 ]
Derks, Terry G. [5 ]
Mou, Jiani [6 ]
Poma, Allen [6 ]
Crombez, Eric [6 ]
机构
[1] Univ Connecticut, Farmington, CT USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Univ Texas McGovern Med Sch, Houston, TX USA
[4] Montreal Childrens Hosp, Montreal, PQ, Canada
[5] Univ Groningen, Groningen, Netherlands
[6] Ultragenyx Gene Therapy, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1306
引用
收藏
页码:558 / 558
页数:1
相关论文
共 41 条
  • [21] Long-Term Rescue of a Hypomorphic Lethal Murine Model of Citrullinemia Type I by Liver-Directed, AAV8-Mediated Gene Therapy
    Wang, Lili
    White, John
    He, Zhenning
    McMenamin, Deirdre
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 114 - 114
  • [22] Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice
    Gibson, Rebecca A.
    Lim, Jeong-A
    Choi, Su Jin
    Koch, Rebecca L.
    Bali, Deeksha
    Young, Sarah
    Jeck, William
    Sun, Baodong
    Asokan, Aravind
    Kishnani, Priya S.
    MOLECULAR THERAPY, 2022, 30 (04) : 478 - 479
  • [23] Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease
    Ferla, Rita
    Haskins, Mark
    Auricchio, Alberto
    MOLECULAR THERAPY, 2012, 20 : S55 - S55
  • [24] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset OTC Deficiency: Results from a Phase 1/2 Clinical Trial
    Tan, Wen-Hann
    Geberhiwot, Tarekegn
    Couce, Maria Luz
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Harding, Cary O.
    Khan, Aneal
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    MOLECULAR THERAPY, 2020, 28 (04) : 222 - 222
  • [25] Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy
    Wang, LL
    Calcedo, R
    Nichols, TC
    Bellinger, DA
    Dillow, A
    Verma, IM
    Wilson, JM
    BLOOD, 2005, 105 (08) : 3079 - 3086
  • [26] AAV8 gene therapy as a potential treatment for adults with late-onset ornithine transcarbamylase (OTC) deficiency: updated results from a phase 1/2 clinical trial
    Geberhiwot, T.
    Couce, M. L.
    Hualde, L. C.
    Harding, C. O.
    Khan, A.
    Diaz, G. A.
    Tan, W.
    Konczal, L.
    Thomas, J.
    Guffon, N.
    Lee, C.
    Puga, A. C.
    Crombez, E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A9 - A9
  • [27] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset Ornithine Transcarbamylase (OTC) Deficiency: Updated Results from a Phase 1/2 Clinical Trial
    Harding, Cary O.
    Luz Couce, Maria
    Geberhiwot, Tarekegn
    Tan, Wen-Hann
    Khan, Aneal
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    MOLECULAR THERAPY, 2021, 29 (04) : 17 - 17
  • [28] A phase 1/2 clinical trial of AAV8 gene therapy in adults with late-onset OTC deficiency: CAPtivate cohort 1+2 results
    Geberhiwot, T.
    Aldamiz-Echevarria, L.
    Couce, M. L.
    Diaz, G. A.
    Harding, C. O.
    Khan, A.
    Tan, W. H.
    Lee, C.
    Puga, A. C.
    Crombez, E.
    HUMAN GENE THERAPY, 2019, 30 (11) : A18 - A18
  • [29] Results from GALILEO-1, A First-in-Human Clinical Trial of FLT201, an AAV-Gene Therapy, in Adults with Gaucher Disease Type 1
    Goker-Alpan, Ozlem
    Whittaker, Andrew
    Ferrante, Francesca
    MOLECULAR THERAPY, 2024, 32 (05) : 1 - 2
  • [30] Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a
    George, Lindsey A.
    Ragni, Margaret V.
    Samelson-Jones, Ben J.
    Cuker, Adam
    Runoski, Alexa R.
    Cole, Grace
    Wright, Fraser
    Chen, Yifeng
    Hui, Daniel J.
    Wachtel, Katie
    Takefman, Daniel
    Couto, Linda B.
    Reape, Kathleen Z.
    Carr, Marcus E.
    Anguela, Xavier M.
    High, Katherine A.
    BLOOD, 2017, 130